Haiyan Ma

机构：Cell Medica (Switzerland) · ORCID：0000-0001-9582-2856

发表论文 11 篇 · 总被引 172 次 · h-index 5

代表论文

• Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study (2021 · JHEP Reports · 被引 62)
• Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces marneffei Infection in HIV-Negative Children (2019 · Frontiers in Immunology · 被引 42)
• The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses (2025 · Gastroenterology · 被引 32)
• 378 HEPATITIS B CORE (HBC) PROTEIN IS A KEY AND VERY EARLY NEGATIVE REGULATOR OF THE INTERFERON RESPONSE (2013 · Journal of Hepatology · 被引 18)
• NLRP3 Inflammasome Contributes to Host Defense Against Talaromyces marneffei Infection (2021 · Frontiers in Immunology · 被引 14)
• OS-050 Therapeutic vaccine (BRII-179) induced immune response associated with HBsAg reduction in a subset of chronic hepatitis B participants (2024 · Journal of Hepatology · 被引 3)